South & Central America Genotyping Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product and Services (Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services), Technology [Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others], Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others)

Name: South & Central America Genotyping Market
SKU: Pharmaceuticals
Rating: 4.7 (30 reviews)

The genotyping market in South & Central America is expected to grow from US$ 772.17 million in 2022 to US$ 1,889.89 million by 2028. It is estimated to grow at a CAGR of 16.1% from 2022 to 2028.

According to the study, personalized medicine is the customization of medical treatment to each patient's unique traits. The method is based on scientific advances in understanding how a person's unique molecular and genetic profile influences susceptibility to diseases and predicts which medical treatments are safe and effective and which are not. Senior government officials, corporate leaders, healthcare practitioners, and the general public have embraced genomics and personalized medicine over the last decade. Genomic medicine is a fundamental component of personalized medicine, a fast-growing health care branch guided by each person's unique clinical, genetic, genomic, and environmental information.

The fundamentals of genomic and personalized medicine will require the development, standardization, and integration of several essential tools into health systems and clinical workflows as medicine embraces genomic tools that enable more precise disease prediction and treatment, such as "whole-genome" interrogation of sequence variation, transcription, proteins, and metabolites. Among the techniques available are health risk assessment, family health history, and clinical decision assistance for complex risk and predictive information.

When combined with genomic data, these tools will enable a paradigm change toward a holistic strategy that will detect individual risks and guide clinical treatment and decision-making, laying the groundwork for a more informed and effective patient care approach. Genome-guided therapy, dose selection, DNA-based risk assessment for common complex diseases, and molecular signatures for cancer diagnosis and prognosis are examples of how genome information has already enabled personalized healthcare. For instance, genome-guided treatment is perhaps the most well-studied effect of precision medicine on health care today.

Clinicians have used genotype data as a guideline to calculate the correct warfarin dose. To assist doctors in optimizing pharmacological therapy based on genetic test results, the Clinical Pharmacogenetics Implementation Consortium produced genotype-based drug guidelines. For individuals with breast or lung cancer, genomic analysis of tumors can help guide tailored therapeutic approaches. When precision medicine is integrated into healthcare, it can provide more accurate diagnoses, anticipate disease risk before symptoms appear, and provide individualized treatment plans that maximize safety and efficiency.

Furthermore, data from individual genomes, a rapidly developing technology area, is causing a social and information revolution among customers, undoubtedly influencing healthcare decision-making. Although these and other scientific discoveries are making their way from the lab to the clinic, widespread acceptance of genomic and personalized medicine will necessitate significant changes in regulatory and reimbursement procedures and legislative privacy laws. Thus, customized healthcare challenges will be met and overcome with the assurance that the research behind genetic medicine is decent and that the practice of medicine that it informs is evidence-based. Over time, there has been a steady trend away from the old 'one pill fits all' strategy and toward a more individualized, patient-centered approach. Patients, health, and diseases are now treated with a more predictive, preventive, participatory, and individualized approach in medicine. This so-called P4 medicine has numerous problems and roadblocks, but it also presents numerous opportunities for improving care and therapeutic outcomes; therefore, such developments will represent a demand for personalized medicine, offering a growth curve for the market over the study period.

South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

South & Central America Genotyping Market Segmentation

The South & Central America genotyping market is segmented by products and services, technology, application, end user, and country. Based on products and services, the market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagents and kits segment is dominating the market in 2022.

Based on technology, the market is segmented into microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption/ionization-time of flight (Maldi-ToF) mass spectrometry, polymerase chain reaction (PCR), and others. The PCR segment is dominating the market in 2022.

Based on application, the market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. The diagnostics and personalized medicine segment is dominating the market in 2022.

Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. The diagnostics and research laboratories segment is dominating the market in 2022.

Based on country, the market is segmented into Brazil, Argentina, and the rest of South & Central America. Further, Brazil is dominating the market in 2022.

A few key players dominating the South & Central America genotyping market are BioTek Instruments, Inc.; F. Hoffmann-La Roche Ltd.; Illumina, Inc.; Integrated DNA Technologies, Inc.; MERCK KGaA; QIAGEN; and Thermo Fisher Scientific Inc.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 South & Central America Genotyping Market – By Product and Services

1.3.2 South & Central America Genotyping Market – By Technology

1.3.3 South & Central America Genotyping Market – By Application

1.3.4 South & Central America Genotyping Market – By End User

1.3.5 South & Central America Genotyping Market – By Country

2. South & Central America Genotyping Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Genotyping Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 South & Central America PEST Analysis

4.3 Experts Opinion

5. South & Central America Genotyping Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases

5.1.2 Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology

5.2 Market Restraints

5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process

5.3 Market Opportunities

5.3.1 Wide Applications of Genotyping

5.4 Future Trends

5.4.1 Rising focus on Personalized Medicine

5.5 Impact analysis

6. Genotyping Market– South & Central America Analysis

6.1 South & Central America Genotyping Market Revenue Forecast and Analysis

7. South & Central America Genotyping Market– by Product and Services

7.1 Overview

7.2 South & Central America Genotyping Market, By Product and Services, 2022 & 2028 (%)

7.3 Reagents and Kits

7.3.1 Overview

7.3.2 Reagents and Kits: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Genotyping Services

7.4.1 Overview

7.4.2 Genotyping Services: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Bioinformatics

7.5.1 Overview

7.5.2 Bioinformatics: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

7.6 Instruments

7.6.1 Overview

7.6.2 Instruments: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

8. South & Central America Genotyping Market– by Technology

8.1 Overview

8.2 South & Central America Genotyping Market Share by Technology - 2022 & 2028 (%)

8.3 Polymerase Chain Reaction (PCR)

8.3.1 Overview

8.3.2 Polymerase Chain Reaction: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.4 Capillary Electrophoresis (CE)

8.4.1 Overview

8.4.2 Capillary Electrophoresis: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.5 Sequencing

8.5.1 Overview

8.5.2 Sequencing: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.6 Microarrays

8.6.1 Overview

8.6.2 Microarrays: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry

8.7.1 Overview

8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Genotyping Market–by Application

9.1 Overview

9.2 South & Central America Genotyping Market Share by Application - 2022 & 2028 (%)

9.3 Diagnostics and Personalized Medicine

9.3.1 Overview

9.3.2 Diagnostics and Personalized Medicine: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9.4 Pharmacogenomics

9.4.1 Overview

9.4.2 Pharmacogenomics: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9.5 Animal Genetics

9.5.1 Overview

9.5.2 Animal Genetics: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9.6 Agricultural Biotechnology

9.6.1 Overview

9.6.2 Agricultural Biotechnology: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

9.7 Others

9.7.1 Overview

9.7.2 Others: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Genotyping Market– by End User

10.1 Overview

10.2 South & Central America Genotyping Market Share by End User- 2022 & 2028 (%)

10.3 Diagnostic and Research Laboratories

10.3.1 Overview

10.3.2 Diagnostic and Research Laboratories: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

10.4 Pharmaceutical and Biopharmaceutical Companies

10.4.1 Overview

10.4.2 Pharmaceutical and Biopharmaceutical Companies: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

10.5 Academic Institutes

10.5.1 Overview

10.5.2 Academic Institutes: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: South & Central America Genotyping Market Revenue and Forecast to 2028 (US$ Million)

11. South & Central America Genotyping Market– Country Analysis

11.1 South & Central America Genotyping Market Revenue and Forecasts to 2028

11.1.1 Overview

11.1.3 South & Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)

11.1.3.1 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.1.3.1.1 Overview

11.1.3.1.2 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.1.3.1.3 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

11.1.3.1.4 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.3.1.5 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.1.3.1.6 Argentina: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.1.3.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.1.3.2.1 Overview

11.1.3.2.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

11.1.3.2.3 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

11.1.3.2.4 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.3.2.5 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.1.3.2.6 Brazil: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

11.1.3.3 Rest of South & Central America: Genotyping Market– Revenue and Forecast to 2028 (USD Mn)

11.1.3.3.1 Overview

11.1.3.3.2 Rest of South & Central America: Genotyping Market– Revenue and Forecast to 2028 (USD Mn)

11.1.3.3.3 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

11.1.3.3.4 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

11.1.3.3.5 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.1.3.3.6 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

12. South & Central America Genotyping Market Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 F. HOFFMANN-LA ROCHE LTD.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 MERCK KGaA

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 THERMO FISHER SCIENTIFIC INC.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 BioTek Instruments, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Illumina, Inc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. South & Central America Genotyping Market –Revenue and Forecast to 2028 (US$ Million)

Table 2. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

Table 3. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 4. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 5. Argentina: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 6. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

Table 7. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 8. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 9. Brazil: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 10. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)

Table 11. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 12. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 13. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)

Table 14. Organic Developments Done By Companies

Table 15. Inorganic Developments Done By Companies

Table 16. Glossary of Terms

LIST OF FIGURES

Figure 1. South & Central America Genotyping Market Segmentation

Figure 2. South & Central America Genotyping Market – By Country

Figure 3. South & Central America Genotyping Market Overview

Figure 4. Reagents and Kits Held Largest Share by Product and Services of South & Central America Genotyping Market

Figure 5. Brazil to Show Significant Growth During Forecast Period

Figure 6. South & Central America: PEST Analysis

Figure 7. Experts Opinion

Figure 8. South & Central America Genotyping Market Impact Analysis of Driver and Restraints

Figure 9. South & Central America Genotyping Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 10. South & Central America Genotyping Market, by Product and Services, 2022 & 2028 (%)

Figure 11. Reagents and Kits: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Genotyping Services: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Bioinformatics: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Instruments: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. South & Central America Genotyping Market Share by Technology - 2022 & 2028 (%)

Figure 16. Polymerase Chain Reaction: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Capillary Electrophoresis: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Sequencing: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Microarrays: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Others: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. South & Central America Genotyping Market Share by Application - 2022 & 2028 (%)

Figure 23. Diagnostics and Personalized Medicine: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Pharmacogenomics: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Animal Genetics: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Agricultural Biotechnology: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Others: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. South & Central America Genotyping Market Share by End User- 2022 & 2028 (%)

Figure 29. Diagnostic and Research Laboratories: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30. Pharmaceutical and Biopharmaceutical Companies: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31. Academic Institutes: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32. Others: South & Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33. South & Central America Genotyping Market Revenue Overview, by Country, 2022 (US$ Million)

Figure 34. South & Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)

Figure 35. Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36. Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37. Rest of South and Central America: Genotyping Market– Revenue and Forecast to 2028 (USD Mn)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America Genotyping Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Genotyping Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the Genotyping Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
South America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
South and Central America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission,..	May 2022
South and Central America In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syring..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000